It's time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials

Medical Journal of Australia

Volumn 193, Issue 1, 2010, Pages 61-

  Sikaris, Kenneth A ^a  

^a MELBOURNE PATHOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; HUMAN; IMMUNOASSAY; LETTER; PROSTATE CANCER; REFERENCE VALUE; SCREENING TEST; SENSITIVITY ANALYSIS;

EID: 77955629899     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03750.x     Document Type: Letter

References (6)

1. Denham JW, Bender R, Paradice WEJ. It's time to depolarise the unhelpful PSA-testing debate and put into practice lessons from the two major international screening trials. Med J Aust 2010; 192: 393-396.
2. Lam QT, Frydenberg M. Strategies for detecting prostate cancer. Common Sense Pathology 2009; (March): 1-8. http://www.rcpa.edu.au/static/File/ Asset%20library/public%20documents/Publications/ Common%20Sense%20Pathology/ Prostate% 20Cancer%20-%20March%202009%20edition.pdf (accessed May 2010).
3. Dennis PM, Stringer MA, Sikaris KA. Causes for concern with the use of PSA assays. Med J Aust 1994; 161: 230.
4. Ablin RJ. The great prostate mistake. New York Times 2010; 9 Mar. http://www.nytimes.com/2010/ 03/10/opinion/10Ablin.html (accessed May 2010).
5. Andriole GL, Crawford ED, Grubb RL, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-1319.
6. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.